波士顿 - 目前市值为877万美元、股价为6.96美元的微型生物科技公司Sensei Biotherapeutics, Inc. (NASDAQ: SNSE )将在即将于柏林举行的欧洲肿瘤内科学会大会上展示其solnerstotug单药及与Regeneron的PD-1抑制剂Libtayo (cemiplimab)联合用药的1/2期临床试验数据。根据 InvestingPro ...

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and ...

Ordering dead drops and paying off your debts in Schedule 1 will have you befriending your suppliers in no time. Once you've reached a loyal relationship ...

Furthermore, additional regulators of thymus homing in the steady state and following BMT have been identified, including PSGL-1, the ligand for P-Selectin (80, 92), and lymphotoxin beta receptor ...

研究人员发现mTORC2缺失可降低肿瘤微环境酸度并减少PSGL-1表达，联合抗VISTA治疗显著抑制肿瘤生长，为LUSC的联合免疫治疗提供了新靶点。

Moreover, the risk score showed a significant positive correlation with the expression levels of seven immune checkpoints, including CD40, OX40, TNFRSF9, TNFRSF14, TNFSF18, TNFRSF25, CD70, PSGL-1, ...

In The Sandman’s first season, Lord Morpheus (Tom Sturridge) escaped from 106 years of captivity and immediately got to work rebuilding his realm and reestablishing his place in the grand ...

Agonists of immune checkpoint modulators for treating autoimmune and inflammatory disorders have shown high potential in immunotherapy. P-selectin glycoprotein ligand 1 (PSGL-1) is known to exert ...

Here's the answer for "Wordle" #1473 on July 1 as well as a few hints, tips, and clues to help you solve it yourself.